Sirolimus (marketed as Rapamune) Information
.
Healthcare Professional Information
- Information for Healthcare Professionals: Immunosuppressant Drugs: Required Labeling Changes
- Sirolimus (marketed as Rapamune)
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
.